Page last updated: 2024-11-01

nevirapine and Precursor Cell Lymphoblastic Leukemia-Lymphoma

nevirapine has been researched along with Precursor Cell Lymphoblastic Leukemia-Lymphoma in 3 studies

Nevirapine: A potent, non-nucleoside reverse transcriptase inhibitor used in combination with nucleoside analogues for treatment of HIV INFECTIONS and AIDS.
nevirapine : A dipyridodiazepine that is 5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepine which is substituted by methyl, oxo, and cyclopropyl groups at positions 4, 6, and 11, respectively. A non-nucleoside reverse transcriptase inhibitor with activity against HIV-1, it is used in combination with other antiretrovirals for the treatment of HIV infection.

Precursor Cell Lymphoblastic Leukemia-Lymphoma: A neoplasm characterized by abnormalities of the lymphoid cell precursors leading to excessive lymphoblasts in the marrow and other organs. It is the most common cancer in children and accounts for the vast majority of all childhood leukemias.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Radi, M1
Maga, G1
Alongi, M1
Angeli, L1
Samuele, A1
Zanoli, S1
Bellucci, L1
Tafi, A1
Casaluce, G1
Giorgi, G1
Armand-Ugon, M1
Gonzalez, E1
Esté, JA1
Baltzinger, M1
Bec, G1
Dumas, P1
Ennifar, E1
Botta, M1
Yan, ZH1
Wu, HQ1
Chen, WX1
Wu, Y1
Piao, HR1
He, QQ1
Chen, FE1
De Clercq, E2
Pannecouque, C2
Sang, Y1
Han, S1
Zhuang, C1
Chen, F1

Other Studies

3 other studies available for nevirapine and Precursor Cell Lymphoblastic Leukemia-Lymphoma

ArticleYear
Discovery of chiral cyclopropyl dihydro-alkylthio-benzyl-oxopyrimidine (S-DABO) derivatives as potent HIV-1 reverse transcriptase inhibitors with high activity against clinically relevant mutants.
    Journal of medicinal chemistry, 2009, Feb-12, Volume: 52, Issue:3

    Topics: Cell Line, Tumor; Computer Simulation; Drug Design; Drug Resistance, Viral; HIV Reverse Transcriptas

2009
Synthesis and biological evaluation of CHX-DAPYs as HIV-1 non-nucleoside reverse transcriptase inhibitors.
    Bioorganic & medicinal chemistry, 2014, Jun-15, Volume: 22, Issue:12

    Topics: Anti-HIV Agents; Benzamides; Cell Survival; Cells, Cultured; Drug Design; HIV Reverse Transcriptase;

2014
Ligand-Based Design of Nondimethylphenyl-Diarylpyrimidines with Improved Metabolic Stability, Safety, and Oral Pharmacokinetic Profiles.
    Journal of medicinal chemistry, 2019, 12-26, Volume: 62, Issue:24

    Topics: Administration, Oral; Animals; Anti-HIV Agents; Apoptosis; Drug Design; Female; HIV Infections; HIV-

2019